压力与冠心病的相关性研究及越鞠丸对压力致病的干预作用
[Abstract]:Purpose 1. The prospective cohort study on the relationship between perceived pressure and coronary heart disease was summarized, and the correlation between perceived pressure and coronary heart disease was studied by meta analysis combined with statistics. To observe the changes of inflammatory reaction markers in serum of rats under pressure, to explore the promoting effect of pressure on the pathogenesis of coronary heart disease from the angle of inflammation, and to observe the intervention effect of traditional Chinese medicine in the occurrence of pressure-induced inflammation with Yueju pills. Further clarify the efficacy of Yueju pill, give full play to the advantages of traditional Chinese medicine, and find an effective way to prevent coronary heart disease caused by stress. Methods: meta analysis: firstly, the inclusion / exclusion criteria of the literature were determined, and then the three foreign language databases, Pubmed, EMBASE, The Cochrane Library, were searched. The retrieval time was from January 1990 to February 2016. The key words were coronary heart disease and psychological stress. After the retrieval, the Endnote software is imported, the results of the retrieval are merged, and the duplicate documents are removed. Select the qualified research, evaluate the quality of the included research, and extract the required information in the research according to the inclusion criteria, and input the data into the Revman5.3 for statistical summary. 2. Animal experiment: divided into blank group, physiological saline group, Yueju pill low dose group, Yueju pill high dose group, Delixin group (western medicine group) 5 groups. Pressure stimulation was given to the latter 4 groups, and the corresponding drugs were given orally once a day for 3 weeks. After that, serum corticosterone IL-6, hs-CRP, sICAM-1 were detected in rat serum and E selectin in aorta. Results one of the 8 studies included in the meta-analysis was the sum of diagnosis and death of coronary heart disease. In two of the eight studies, a common stress measurement scale was used. In the rest of the studies, the subjects were rated for the stress they felt and assigned to different stress groups according to their scores; except for one study, the number of cases was 211. The rest were above 1000, except for the RR of 2 studies which were not adjusted for other risk factors, and the others were adjusted for common risk factors of coronary heart disease. After QUADAS quality evaluation, the overall quality of selected literature is good. The RR of pressure-induced coronary heart disease was 1.25 (1.15-1.35) (95% CI), and the pressure was positively correlated with the risk of coronary heart disease. There is no heterogeneity in the study. The levels of corticosterone hs-CRP, ICAM-1 and E- selectin in aorta were increased in the pressure-stimulated rats, indicating the occurrence of inflammatory reaction, and the content of inflammatory markers decreased after the intervention of Yueju pills. The effect of Yueju pill was similar to that of Delixin. The dose effect of Yueju pill was only found in the determination of hs-CRP content. There was no significant difference in the content of IL-6 between groups. Conclusion: stress can increase the risk of coronary heart disease and may be one of the potential risk factors of coronary heart disease. The levels of corticosterone CRP and ICAM-1 in the serum of rats under pressure increased, indicating the occurrence of inflammatory reaction and increasing the risk of coronary heart disease, and the content of inflammatory markers decreased after the intervention of Yueju pills. The overall efficacy was similar to that of Delixine, and there was no significant dose effect of Yueju pill. There was no significant change in the content of IL-6 in stress rats. Considering the shorter modeling time, it is not enough to show the obvious difference.
【学位授予单位】:广州中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 钟光华;越鞠丸加减治疗痛证举隅[J];中国民间疗法;2001年05期
2 成金汉;邓金强;;越鞠丸治疗中风后抑郁32例[J];临床医药实践;2009年33期
3 李素琴;;越鞠丸加减治疗2型糖尿病68例疗效观察[J];山西中医学院学报;2009年06期
4 朱洪海;;越鞠丸临床应用研究进展述略[J];实用中医内科杂志;2010年11期
5 王鹰;云端;;越鞠丸临床运用[J];中国中医药现代远程教育;2011年16期
6 吴四平;;浅谈“越鞠丸”名方[J];中医临床研究;2011年07期
7 王贝贝;屈艳艳;;越鞠丸治疗失眠54例[J];山东中医杂志;2012年02期
8 冯笑予;高嵩山;;越鞠丸治疗痰浊阻遏型高脂血症患者疗效观察[J];黑龙江医学;2013年09期
9 来春茂;越鞠丸临床运用经验[J];新中医;1974年05期
10 李志文;;越鞠丸的临床应用[J];吉林中医药;1984年03期
相关会议论文 前1条
1 初玉平;张振国;;越鞠丸临床应用举隅[A];全国中成药学术研讨会论文汇编[C];1994年
相关重要报纸文章 前6条
1 陈良玉;越鞠丸三种新用途[N];医药养生保健报;2006年
2 杨桢邋高琳;灵活辨证治脾胃的范本——越鞠丸[N];中国医药报;2008年
3 鲍正飞;越鞠丸治疗不寐[N];中国中医药报;2007年
4 亚文;越鞠丸治疗不寐[N];农村医药报(汉);2009年
5 河南省中医院 王立忠;六郁与越鞠丸[N];中国中医药报;2009年
6 王成英;中医治郁主调气[N];大众卫生报;2004年
相关硕士学位论文 前4条
1 王s,
本文编号:2195104
本文链接:https://www.wllwen.com/zhongyixuelunwen/2195104.html